Industry Research Reports

Home > Reports > Chemical & Material > Global Vitamin B3 (Nicotinamide) Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Vitamin B3 (Nicotinamide) Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-03

Pages: 151 Pages

Report ld: 5109377

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Vitamin B3 (Nicotinamide) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Vitamin B3, also known as niacinamide, is an important water-soluble vitamin. Nicotinamide (nicotinamide) is a form of vitamin B3, also known as nicotinamide or niacinamide. It is a white crystalline powder, soluble in water and ethanol. Nicotinamide participates in a variety of biochemical reactions in the human body, including energy metabolism, DNA repair and gene expression. It is also an important antioxidant that protects cells from free radical damage. Additionally, Nicotinamide has been linked to skin health and can be used to treat certain skin conditions.

From a downstream perspective, Pharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Vitamin B3 (Nicotinamide) leading manufacturers including Vertellus, Lasons India, DSM, Lonza, Vanetta, Lamberts Healthcare, Jubilant Life Sciences, Brother Enterprises, Resonance Specialties, MedicaLine, etc., dominate supply; the top five capture approximately % of global revenue, with Vertellus leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Vitamin B3 (Nicotinamide) market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Vertellus
Lasons India
DSM
Lonza
Vanetta
Lamberts Healthcare
Jubilant Life Sciences
Brother Enterprises
Resonance Specialties
MedicaLine
Nature's Way
FENGCHEN GROUP
Tianjin Zhongrui Pharmaceutical
Zhejiang Lanbo Biotechnology

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Food Grade
Pharmaceutical Grade

Segment by Application

Pharmaceutical
Food

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Vitamin B3 (Nicotinamide) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Vitamin B3 (Nicotinamide): Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Vitamin B3 (Nicotinamide) Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Food Grade

1.2.3 Pharmaceutical Grade

1.3 Market Segmentation by Application

1.3.1 Global Vitamin B3 (Nicotinamide) Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical

1.3.3 Food

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Vitamin B3 (Nicotinamide) Revenue Estimates and Forecasts 2020-2031

2.2 Global Vitamin B3 (Nicotinamide) Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Vitamin B3 (Nicotinamide) Sales Estimates and Forecasts 2020-2031

2.4 Global Vitamin B3 (Nicotinamide) Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Vitamin B3 (Nicotinamide) Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Vitamin B3 (Nicotinamide) Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Vitamin B3 (Nicotinamide) Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Food Grade Market Size by Manufacturers

4.5.2 Pharmaceutical Grade Market Size by Manufacturers

4.6 Global Vitamin B3 (Nicotinamide) Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Vitamin B3 (Nicotinamide) Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Vitamin B3 (Nicotinamide) Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Vitamin B3 (Nicotinamide) Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Vitamin B3 (Nicotinamide) Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Vitamin B3 (Nicotinamide) Sales and Revenue by Type (2020-2031)

7.4 North America Vitamin B3 (Nicotinamide) Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Vitamin B3 (Nicotinamide) Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Vitamin B3 (Nicotinamide) Sales and Revenue by Type (2020-2031)

8.4 Europe Vitamin B3 (Nicotinamide) Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Vitamin B3 (Nicotinamide) Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Vitamin B3 (Nicotinamide) Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Vitamin B3 (Nicotinamide) Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Vitamin B3 (Nicotinamide) Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Vitamin B3 (Nicotinamide) Sales and Revenue by Type (2020-2031)

10.4 Central and South America Vitamin B3 (Nicotinamide) Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Vitamin B3 (Nicotinamide) Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Vitamin B3 (Nicotinamide) Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Vitamin B3 (Nicotinamide) Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Vitamin B3 (Nicotinamide) Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Vertellus

12.1.1 Vertellus Corporation Information

12.1.2 Vertellus Business Overview

12.1.3 Vertellus Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.1.4 Vertellus Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Vertellus Vitamin B3 (Nicotinamide) Sales by Product in 2024

12.1.6 Vertellus Vitamin B3 (Nicotinamide) Sales by Application in 2024

12.1.7 Vertellus Vitamin B3 (Nicotinamide) Sales by Geographic Area in 2024

12.1.8 Vertellus Vitamin B3 (Nicotinamide) SWOT Analysis

12.1.9 Vertellus Recent Developments

12.2 Lasons India

12.2.1 Lasons India Corporation Information

12.2.2 Lasons India Business Overview

12.2.3 Lasons India Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.2.4 Lasons India Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Lasons India Vitamin B3 (Nicotinamide) Sales by Product in 2024

12.2.6 Lasons India Vitamin B3 (Nicotinamide) Sales by Application in 2024

12.2.7 Lasons India Vitamin B3 (Nicotinamide) Sales by Geographic Area in 2024

12.2.8 Lasons India Vitamin B3 (Nicotinamide) SWOT Analysis

12.2.9 Lasons India Recent Developments

12.3 DSM

12.3.1 DSM Corporation Information

12.3.2 DSM Business Overview

12.3.3 DSM Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.3.4 DSM Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 DSM Vitamin B3 (Nicotinamide) Sales by Product in 2024

12.3.6 DSM Vitamin B3 (Nicotinamide) Sales by Application in 2024

12.3.7 DSM Vitamin B3 (Nicotinamide) Sales by Geographic Area in 2024

12.3.8 DSM Vitamin B3 (Nicotinamide) SWOT Analysis

12.3.9 DSM Recent Developments

12.4 Lonza

12.4.1 Lonza Corporation Information

12.4.2 Lonza Business Overview

12.4.3 Lonza Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.4.4 Lonza Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Lonza Vitamin B3 (Nicotinamide) Sales by Product in 2024

12.4.6 Lonza Vitamin B3 (Nicotinamide) Sales by Application in 2024

12.4.7 Lonza Vitamin B3 (Nicotinamide) Sales by Geographic Area in 2024

12.4.8 Lonza Vitamin B3 (Nicotinamide) SWOT Analysis

12.4.9 Lonza Recent Developments

12.5 Vanetta

12.5.1 Vanetta Corporation Information

12.5.2 Vanetta Business Overview

12.5.3 Vanetta Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.5.4 Vanetta Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Vanetta Vitamin B3 (Nicotinamide) Sales by Product in 2024

12.5.6 Vanetta Vitamin B3 (Nicotinamide) Sales by Application in 2024

12.5.7 Vanetta Vitamin B3 (Nicotinamide) Sales by Geographic Area in 2024

12.5.8 Vanetta Vitamin B3 (Nicotinamide) SWOT Analysis

12.5.9 Vanetta Recent Developments

12.6 Lamberts Healthcare

12.6.1 Lamberts Healthcare Corporation Information

12.6.2 Lamberts Healthcare Business Overview

12.6.3 Lamberts Healthcare Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.6.4 Lamberts Healthcare Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Lamberts Healthcare Recent Developments

12.7 Jubilant Life Sciences

12.7.1 Jubilant Life Sciences Corporation Information

12.7.2 Jubilant Life Sciences Business Overview

12.7.3 Jubilant Life Sciences Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.7.4 Jubilant Life Sciences Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Jubilant Life Sciences Recent Developments

12.8 Brother Enterprises

12.8.1 Brother Enterprises Corporation Information

12.8.2 Brother Enterprises Business Overview

12.8.3 Brother Enterprises Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.8.4 Brother Enterprises Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Brother Enterprises Recent Developments

12.9 Resonance Specialties

12.9.1 Resonance Specialties Corporation Information

12.9.2 Resonance Specialties Business Overview

12.9.3 Resonance Specialties Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.9.4 Resonance Specialties Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Resonance Specialties Recent Developments

12.10 MedicaLine

12.10.1 MedicaLine Corporation Information

12.10.2 MedicaLine Business Overview

12.10.3 MedicaLine Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.10.4 MedicaLine Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 MedicaLine Recent Developments

12.11 Nature's Way

12.11.1 Nature's Way Corporation Information

12.11.2 Nature's Way Business Overview

12.11.3 Nature's Way Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.11.4 Nature's Way Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Nature's Way Recent Developments

12.12 FENGCHEN GROUP

12.12.1 FENGCHEN GROUP Corporation Information

12.12.2 FENGCHEN GROUP Business Overview

12.12.3 FENGCHEN GROUP Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.12.4 FENGCHEN GROUP Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 FENGCHEN GROUP Recent Developments

12.13 Tianjin Zhongrui Pharmaceutical

12.13.1 Tianjin Zhongrui Pharmaceutical Corporation Information

12.13.2 Tianjin Zhongrui Pharmaceutical Business Overview

12.13.3 Tianjin Zhongrui Pharmaceutical Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.13.4 Tianjin Zhongrui Pharmaceutical Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Tianjin Zhongrui Pharmaceutical Recent Developments

12.14 Zhejiang Lanbo Biotechnology

12.14.1 Zhejiang Lanbo Biotechnology Corporation Information

12.14.2 Zhejiang Lanbo Biotechnology Business Overview

12.14.3 Zhejiang Lanbo Biotechnology Vitamin B3 (Nicotinamide) Product Models, Descriptions and Specifications

12.14.4 Zhejiang Lanbo Biotechnology Vitamin B3 (Nicotinamide) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.5 Zhejiang Lanbo Biotechnology Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Vitamin B3 (Nicotinamide) Industry Chain

13.2 Vitamin B3 (Nicotinamide) Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Vitamin B3 (Nicotinamide) Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Vitamin B3 (Nicotinamide) Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Vitamin B3 (Nicotinamide) Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Vitamin B3 (Nicotinamide) Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Vitamin B3 (Nicotinamide) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Vitamin B3 (Nicotinamide) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Vitamin B3 (Nicotinamide) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Vitamin B3 (Nicotinamide) Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Vitamin B3 (Nicotinamide) Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Vitamin B3 (Nicotinamide) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 7. Global Vitamin B3 (Nicotinamide) Sales by Region (2020-2025) & (Tons)

Table 8. Global Vitamin B3 (Nicotinamide) Sales by Region (2026-2031) & (Tons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Vitamin B3 (Nicotinamide) Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 11. Global Vitamin B3 (Nicotinamide) Production by Region (2020-2025) & (Tons)

Table 12. Global Vitamin B3 (Nicotinamide) Production by Region (2026-2031) & (Tons)

Table 13. Global Vitamin B3 (Nicotinamide) Sales by Manufacturers (2020-2025) & (Tons)

Table 14. Global Vitamin B3 (Nicotinamide) Sales Share by Manufacturers (2020-2025)

Table 15. Global Vitamin B3 (Nicotinamide) Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Vitamin B3 (Nicotinamide) Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Vitamin B3 (Nicotinamide) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin B3 (Nicotinamide) as of 2024)

Table 19. Global Vitamin B3 (Nicotinamide) Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Vitamin B3 (Nicotinamide) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)

Table 21. Key Manufacturers Vitamin B3 (Nicotinamide) Manufacturing Base and Headquarters

Table 22. Global Vitamin B3 (Nicotinamide) Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Vitamin B3 (Nicotinamide) Sales by Type (2020-2025) & (Tons)

Table 26. Global Vitamin B3 (Nicotinamide) Sales by Type (2026-2031) & (Tons)

Table 27. Global Vitamin B3 (Nicotinamide) Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Vitamin B3 (Nicotinamide) Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Vitamin B3 (Nicotinamide) ASP by Type (2020-2031) & (US$/Ton)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Vitamin B3 (Nicotinamide) Sales by Application (2020-2025) & (Tons)

Table 32. Global Vitamin B3 (Nicotinamide) Sales by Application (2026-2031) & (Tons)

Table 33. Vitamin B3 (Nicotinamide) High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Vitamin B3 (Nicotinamide) Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Vitamin B3 (Nicotinamide) Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Vitamin B3 (Nicotinamide) ASP by Application (2020-2031) & (US$/Ton)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Vitamin B3 (Nicotinamide) Growth Accelerators and Market Barriers

Table 40. North America Vitamin B3 (Nicotinamide) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Vitamin B3 (Nicotinamide) Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Vitamin B3 (Nicotinamide) Growth Accelerators and Market Barriers

Table 43. Europe Vitamin B3 (Nicotinamide) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Vitamin B3 (Nicotinamide) Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Vitamin B3 (Nicotinamide) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Vitamin B3 (Nicotinamide) Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Vitamin B3 (Nicotinamide) Growth Accelerators and Market Barriers

Table 48. Southeast Asia Vitamin B3 (Nicotinamide) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Vitamin B3 (Nicotinamide) Investment Opportunities and Key Challenges

Table 50. Central and South America Vitamin B3 (Nicotinamide) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Vitamin B3 (Nicotinamide) Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Vitamin B3 (Nicotinamide) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Vertellus Corporation Information

Table 54. Vertellus Description and Major Businesses

Table 55. Vertellus Product Models, Descriptions and Specifications

Table 56. Vertellus Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 57. Vertellus Sales Value Proportion by Product in 2024

Table 58. Vertellus Sales Value Proportion by Application in 2024

Table 59. Vertellus Sales Value Proportion by Geographic Area in 2024

Table 60. Vertellus Vitamin B3 (Nicotinamide) SWOT Analysis

Table 61. Vertellus Recent Developments

Table 62. Lasons India Corporation Information

Table 63. Lasons India Description and Major Businesses

Table 64. Lasons India Product Models, Descriptions and Specifications

Table 65. Lasons India Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 66. Lasons India Sales Value Proportion by Product in 2024

Table 67. Lasons India Sales Value Proportion by Application in 2024

Table 68. Lasons India Sales Value Proportion by Geographic Area in 2024

Table 69. Lasons India Vitamin B3 (Nicotinamide) SWOT Analysis

Table 70. Lasons India Recent Developments

Table 71. DSM Corporation Information

Table 72. DSM Description and Major Businesses

Table 73. DSM Product Models, Descriptions and Specifications

Table 74. DSM Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. DSM Sales Value Proportion by Product in 2024

Table 76. DSM Sales Value Proportion by Application in 2024

Table 77. DSM Sales Value Proportion by Geographic Area in 2024

Table 78. DSM Vitamin B3 (Nicotinamide) SWOT Analysis

Table 79. DSM Recent Developments

Table 80. Lonza Corporation Information

Table 81. Lonza Description and Major Businesses

Table 82. Lonza Product Models, Descriptions and Specifications

Table 83. Lonza Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. Lonza Sales Value Proportion by Product in 2024

Table 85. Lonza Sales Value Proportion by Application in 2024

Table 86. Lonza Sales Value Proportion by Geographic Area in 2024

Table 87. Lonza Vitamin B3 (Nicotinamide) SWOT Analysis

Table 88. Lonza Recent Developments

Table 89. Vanetta Corporation Information

Table 90. Vanetta Description and Major Businesses

Table 91. Vanetta Product Models, Descriptions and Specifications

Table 92. Vanetta Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Vanetta Sales Value Proportion by Product in 2024

Table 94. Vanetta Sales Value Proportion by Application in 2024

Table 95. Vanetta Sales Value Proportion by Geographic Area in 2024

Table 96. Vanetta Vitamin B3 (Nicotinamide) SWOT Analysis

Table 97. Vanetta Recent Developments

Table 98. Lamberts Healthcare Corporation Information

Table 99. Lamberts Healthcare Description and Major Businesses

Table 100. Lamberts Healthcare Product Models, Descriptions and Specifications

Table 101. Lamberts Healthcare Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 102. Lamberts Healthcare Recent Developments

Table 103. Jubilant Life Sciences Corporation Information

Table 104. Jubilant Life Sciences Description and Major Businesses

Table 105. Jubilant Life Sciences Product Models, Descriptions and Specifications

Table 106. Jubilant Life Sciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 107. Jubilant Life Sciences Recent Developments

Table 108. Brother Enterprises Corporation Information

Table 109. Brother Enterprises Description and Major Businesses

Table 110. Brother Enterprises Product Models, Descriptions and Specifications

Table 111. Brother Enterprises Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 112. Brother Enterprises Recent Developments

Table 113. Resonance Specialties Corporation Information

Table 114. Resonance Specialties Description and Major Businesses

Table 115. Resonance Specialties Product Models, Descriptions and Specifications

Table 116. Resonance Specialties Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 117. Resonance Specialties Recent Developments

Table 118. MedicaLine Corporation Information

Table 119. MedicaLine Description and Major Businesses

Table 120. MedicaLine Product Models, Descriptions and Specifications

Table 121. MedicaLine Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 122. MedicaLine Recent Developments

Table 123. Nature's Way Corporation Information

Table 124. Nature's Way Description and Major Businesses

Table 125. Nature's Way Product Models, Descriptions and Specifications

Table 126. Nature's Way Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 127. Nature's Way Recent Developments

Table 128. FENGCHEN GROUP Corporation Information

Table 129. FENGCHEN GROUP Description and Major Businesses

Table 130. FENGCHEN GROUP Product Models, Descriptions and Specifications

Table 131. FENGCHEN GROUP Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 132. FENGCHEN GROUP Recent Developments

Table 133. Tianjin Zhongrui Pharmaceutical Corporation Information

Table 134. Tianjin Zhongrui Pharmaceutical Description and Major Businesses

Table 135. Tianjin Zhongrui Pharmaceutical Product Models, Descriptions and Specifications

Table 136. Tianjin Zhongrui Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 137. Tianjin Zhongrui Pharmaceutical Recent Developments

Table 138. Zhejiang Lanbo Biotechnology Corporation Information

Table 139. Zhejiang Lanbo Biotechnology Description and Major Businesses

Table 140. Zhejiang Lanbo Biotechnology Product Models, Descriptions and Specifications

Table 141. Zhejiang Lanbo Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 142. Zhejiang Lanbo Biotechnology Recent Developments

Table 143. Key Raw Materials Distribution

Table 144. Raw Materials Key Suppliers

Table 145. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 146. Milestones in Production Technology Evolution

Table 147. Distributors List

Table 148. Market Trends and Market Evolution

Table 149. Market Drivers and Opportunities

Table 150. Market Challenges, Risks, and Restraints

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Vitamin B3 (Nicotinamide) Product Picture

Figure 2. Global Vitamin B3 (Nicotinamide) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Food Grade Product Picture

Figure 4. Pharmaceutical Grade Product Picture

Figure 5. Global Vitamin B3 (Nicotinamide) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Pharmaceutical

Figure 7. Food

Figure 8. Vitamin B3 (Nicotinamide) Report Years Considered

Figure 9. Global Vitamin B3 (Nicotinamide) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 10. Global Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 11. Global Vitamin B3 (Nicotinamide) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 12. Global Vitamin B3 (Nicotinamide) Revenue Market Share by Region (2020-2031)

Figure 13. Global Vitamin B3 (Nicotinamide) Sales (2020-2031) & (Tons)

Figure 14. Global Vitamin B3 (Nicotinamide) Sales (CAGR) by Region (2020-2031) (Tons)

Figure 15. Global Vitamin B3 (Nicotinamide) Sales Market Share by Region (2020-2031)

Figure 16. Global Vitamin B3 (Nicotinamide) Capacity, Production and Utilization (2020-2031) & (Tons)

Figure 17. Global Vitamin B3 (Nicotinamide) Production Trend by Region (2020-2031) (Tons)

Figure 18. Global Vitamin B3 (Nicotinamide) Production Market Share by Region (2020-2031)

Figure 19. Production Capacity Enablers & Constraints

Figure 20. Vitamin B3 (Nicotinamide) Production Growth Rate in North America (2020-2031) & (Tons)

Figure 21. Vitamin B3 (Nicotinamide) Production Growth Rate in Europe (2020-2031) & (Tons)

Figure 22. Vitamin B3 (Nicotinamide) Production Growth Rate in China (2020-2031) & (Tons)

Figure 23. Vitamin B3 (Nicotinamide) Production Growth Rate in Japan (2020-2031) & (Tons)

Figure 24. Top 5 and Top 10 Manufacturers Vitamin B3 (Nicotinamide) Sales Volume Market Share in 2024

Figure 25. Global Vitamin B3 (Nicotinamide) Revenue Market Share Ranking (2024)

Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 27. Food Grade Revenue Market Share by Manufacturer in 2024

Figure 28. Pharmaceutical Grade Revenue Market Share by Manufacturer in 2024

Figure 29. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 30. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 31. Global Vitamin B3 (Nicotinamide) Sales Market Share by Type (2020-2031)

Figure 32. Global Vitamin B3 (Nicotinamide) Revenue Market Share by Type (2020-2031)

Figure 33. Global Vitamin B3 (Nicotinamide) Sales Market Share by Application (2020-2031)

Figure 34. Global Vitamin B3 (Nicotinamide) Revenue Market Share by Application (2020-2031)

Figure 35. North America Vitamin B3 (Nicotinamide) Sales YoY (2020-2031) & (Tons)

Figure 36. North America Vitamin B3 (Nicotinamide) Revenue YoY (2020-2031) & (US$ Million)

Figure 37. North America Top 5 Manufacturers Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) in 2024

Figure 38. North America Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Type (2020- 2031)

Figure 39. North America Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 40. North America Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Application (2020-2031)

Figure 41. North America Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 42. US Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 43. Canada Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 44. Mexico Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 45. Europe Vitamin B3 (Nicotinamide) Sales YoY (2020-2031) & (Tons)

Figure 46. Europe Vitamin B3 (Nicotinamide) Revenue YoY (2020-2031) & (US$ Million)

Figure 47. Europe Top 5 Manufacturers Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) in 2024

Figure 48. Europe Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Type (2020-2031)

Figure 49. Europe Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Type (2020-2031)

Figure 50. Europe Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Application (2020-2031)

Figure 51. Europe Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 52. Germany Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 53. France Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 54. U.K. Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 55. Italy Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 56. Russia Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 57. Asia-Pacific Vitamin B3 (Nicotinamide) Sales YoY (2020-2031) & (Tons)

Figure 58. Asia-Pacific Vitamin B3 (Nicotinamide) Revenue YoY (2020-2031) & (US$ Million)

Figure 59. Asia-Pacific Top 8 Manufacturers Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) in 2024

Figure 60. Asia-Pacific Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Type (2020- 2031)

Figure 61. Asia-Pacific Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 62. Asia-Pacific Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Application (2020-2031)

Figure 63. Asia-Pacific Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 64. Indonesia Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 65. Japan Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 66. South Korea Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 67. China Taiwan Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 68. India Vitamin B3 (Nicotinamide) Revenue (2020-2031) & (US$ Million)

Figure 69. Central and South America Vitamin B3 (Nicotinamide) Sales YoY (2020-2031) & (Tons)

Figure 70. Central and South America Vitamin B3 (Nicotinamide) Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Central and South America Top 5 Manufacturers Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) in 2024

Figure 72. Central and South America Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Type (2021-2031)

Figure 73. Central and South America Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Central and South America Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Application (2020-2031)

Figure 75. Central and South America Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. Brazil Vitamin B3 (Nicotinamide) Revenue (2020-2025) & (US$ Million)

Figure 77. Argentina Vitamin B3 (Nicotinamide) Revenue (2020-2025) & (US$ Million)

Figure 78. Middle East, and Africa Vitamin B3 (Nicotinamide) Sales YoY (2020-2031) & (Tons)

Figure 79. Middle East and Africa Vitamin B3 (Nicotinamide) Revenue YoY (2020-2031) & (US$ Million)

Figure 80. Middle East and Africa Top 5 Manufacturers Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) in 2024

Figure 81. Middle East and Africa Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Type (2021-2031)

Figure 82. South America Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Type (2020-2031)

Figure 83. Middle East and Africa Vitamin B3 (Nicotinamide) Sales Volume (Tons) by Application (2020-2031)

Figure 84. Middle East and Africa Vitamin B3 (Nicotinamide) Sales Revenue (US$ Million) by Application (2020-2031)

Figure 85. GCC Countries Vitamin B3 (Nicotinamide) Revenue (2020-2025) & (US$ Million)

Figure 86. Turkey Vitamin B3 (Nicotinamide) Revenue (2020-2025) & (US$ Million)

Figure 87. Egypt Vitamin B3 (Nicotinamide) Revenue (2020-2025) & (US$ Million)

Figure 88. South Africa Vitamin B3 (Nicotinamide) Revenue (2020-2025) & (US$ Million)

Figure 89. Vitamin B3 (Nicotinamide) Industry Chain Mapping

Figure 90. Regional Vitamin B3 (Nicotinamide) Manufacturing Base Distribution (%)

Figure 91. Vitamin B3 (Nicotinamide) Production Process

Figure 92. Regional Vitamin B3 (Nicotinamide) Production Cost Structure

Figure 93. Channels of Distribution (Direct Vs Distribution)

Figure 94. Bottom-up and Top-down Approaches for This Report

Figure 95. Data Triangulation

Figure 96. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Vitamin B3 (Nicotinamide) market? zhanKai

The top companies in the global Vitamin B3 (Nicotinamide) market are Vertellus、Lasons India、DSM.

Related Reports

Vitamin B3 (Nicotinamide)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Vitamin B3 (Nicotinamide) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-02
Pages: 118
USD 3950.00
(Single User License)
Global Vitamin B3 (Nicotinamide) Market Research Report 2026
The global Vitamin B3 (Nicotinamide) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-02
Pages: 143
USD 2900.00
(Single User License)
Global Vitamin B3 (Nicotinamide) Market Research Report 2025
The global market for Vitamin B3 (Nicotinamide) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-15
Pages: 101
USD 2900.00
(Single User License)
Global Vitamin B3 (Nicotinamide) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Vitamin B3 (Nicotinamide) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 91
USD 4250.00
(Single User License)
Vitamin B3 (Nicotinamide)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vitamin B3 (Nicotinamide) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 129
USD 3950.00
(Single User License)
Global Vitamin B3 (Nicotinamide) Market Insights, Forecast to 2030
Vitamin B3, also known as niacinamide, is an important water-soluble vitamin. Nicotinamide (nicotinamide) is a form of vitamin B3, also known as nicotinamide or niacinamide. It is a white crystalline powder, soluble in water and ethanol. Nicotinamide participates in a variety of biochemical reactions in the human body, including energy metabolism, DNA repair and gene expression. It is also an important antioxidant that protects cells from free radical damage. Additionally, Nicotinamide has been linked to skin health and can be used to treat certain skin conditions.
Published Date: 2024-04-27
Pages: 112
USD 4900.00
(Single User License)
Vitamin B3 (Nicotinamide) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Vitamin B3, also known as niacinamide, is an important water-soluble vitamin. Nicotinamide (nicotinamide) is a form of vitamin B3, also known as nicotinamide or niacinamide. It is a white crystalline powder, soluble in water and ethanol. Nicotinamide participates in a variety of biochemical reactions in the human body, including energy metabolism, DNA repair and gene expression. It is also an important antioxidant that protects cells from free radical damage. Additionally, Nicotinamide has been linked to skin health and can be used to treat certain skin conditions.
Published Date: 2024-02-19
Pages: 126
USD 3950.00
(Single User License)
Global Vitamin B3 (Nicotinamide) Market Research Report 2024
Vitamin B3, also known as niacinamide, is an important water-soluble vitamin. Nicotinamide (nicotinamide) is a form of vitamin B3, also known as nicotinamide or niacinamide. It is a white crystalline powder, soluble in water and ethanol. Nicotinamide participates in a variety of biochemical reactions in the human body, including energy metabolism, DNA repair and gene expression. It is also an important antioxidant that protects cells from free radical damage. Additionally, Nicotinamide has been linked to skin health and can be used to treat certain skin conditions.
Published Date: 2024-01-18
Pages: 102
USD 2900.00
(Single User License)

Vitamin B3 (Nicotinamide)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Vitamin B3 (Nicotinamide) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-02
Pages: 118
USD 3950.00 (Single User License)
Global Vitamin B3 (Nicotinamide) Market Research Report 2026
The global Vitamin B3 (Nicotinamide) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-02
Pages: 143
USD 2900.00 (Single User License)
Global Vitamin B3 (Nicotinamide) Market Research Report 2025
The global market for Vitamin B3 (Nicotinamide) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-15
Pages: 101
USD 2900.00 (Single User License)
Global Vitamin B3 (Nicotinamide) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Vitamin B3 (Nicotinamide) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 91
USD 4250.00 (Single User License)
Vitamin B3 (Nicotinamide)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vitamin B3 (Nicotinamide) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 129
USD 3950.00 (Single User License)
Global Vitamin B3 (Nicotinamide) Market Insights, Forecast to 2030
Vitamin B3, also known as niacinamide, is an important water-soluble vitamin. Nicotinamide (nicotinamide) is a form of vitamin B3, also known as nicotinamide or niacinamide. It is a white crystalline powder, soluble in water and ethanol. Nicotinamide participates in a variety of biochemical reactions in the human body, including energy metabolism, DNA repair and gene expression. It is also an important antioxidant that protects cells from free radical damage. Additionally, Nicotinamide has been linked to skin health and can be used to treat certain skin conditions.
Published: 2024-04-27
Pages: 112
USD 4900.00 (Single User License)
Vitamin B3 (Nicotinamide) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Vitamin B3, also known as niacinamide, is an important water-soluble vitamin. Nicotinamide (nicotinamide) is a form of vitamin B3, also known as nicotinamide or niacinamide. It is a white crystalline powder, soluble in water and ethanol. Nicotinamide participates in a variety of biochemical reactions in the human body, including energy metabolism, DNA repair and gene expression. It is also an important antioxidant that protects cells from free radical damage. Additionally, Nicotinamide has been linked to skin health and can be used to treat certain skin conditions.
Published: 2024-02-19
Pages: 126
USD 3950.00 (Single User License)
Global Vitamin B3 (Nicotinamide) Market Research Report 2024
Vitamin B3, also known as niacinamide, is an important water-soluble vitamin. Nicotinamide (nicotinamide) is a form of vitamin B3, also known as nicotinamide or niacinamide. It is a white crystalline powder, soluble in water and ethanol. Nicotinamide participates in a variety of biochemical reactions in the human body, including energy metabolism, DNA repair and gene expression. It is also an important antioxidant that protects cells from free radical damage. Additionally, Nicotinamide has been linked to skin health and can be used to treat certain skin conditions.
Published: 2024-01-18
Pages: 102
USD 2900.00 (Single User License)